Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process.
Antihypertensive Agents
/ economics
Capacity Building
/ organization & administration
Cost-Benefit Analysis
Costs and Cost Analysis
Ghana
Health Care Rationing
/ organization & administration
Health Policy
Humans
Hypertension
/ drug therapy
Technology Assessment, Biomedical
/ organization & administration
Universal Health Insurance
/ economics
Capacity building
Ghana
Health technology assessment
Universal health coverage
Journal
International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
30
11
2019
medline:
15
12
2020
entrez:
29
11
2019
Statut:
ppublish
Résumé
Ghana is one of the few African countries to enact legislation and earmark significant funding to establish universal health coverage (UHC) through the National Health Insurance Scheme, although donor funds have declined recently. Given a disproportionate level of spending on medicines, health technology assessment (HTA) can support resource allocation decisions in the face of highly constrained budgets, as commonly found in low-resource settings. The Ghanaian Ministry of Health, supported by the International Decision Support Initiative (iDSI), initiated a HTA study in 2016 to examine the cost-effectiveness of antihypertensive medicines. We aimed to summarize key insights from this work that highlights success factors beyond producing purely technical outputs. These include the need for capacity building, academic collaboration, and ongoing partnerships with a broad range of experts and stakeholders. By building on this HTA study, and with ongoing interactions with iDSI, HTAi, WHO, and others, Ghana will be well positioned to institutionalize HTA in resource allocation decisions and support progress toward UHC.
Identifiants
pubmed: 31775950
doi: 10.1017/S0266462319000795
pii: S0266462319000795
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM